Why the study?
Does cardiac resynchronization therapy improve clinical status and mortality in patients with symptomatic heart failure resulting from systolic dysfunction?
Population
Patients with symptomatic heart failure resulting from systolic dysfunction
Design
Guideline
Authors
Loading...
CRT should be considered in selected systolic HF patients; reinforces Level 1 guideline recommendations.
Does cardiac resynchronization therapy improve clinical status and mortality in patients with symptomatic heart failure resulting from systolic dysfunction?
This advisory outlines appropriate patient selection criteria for cardiac resynchronization therapy based on clinical trial evidence showing improved clinical status and mortality in heart failure with systolic dysfunction.
Strickberger et al. (2005) conducted a review in Symptomatic heart failure resulting from systolic dysfunction. Cardiac resynchronization therapy (CRT) was evaluated. Cardiac resynchronization therapy improves clinical status and lowers mortality in selected patients with systolic ventricular dysfunction and heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: